Ipratropium bromide versus short acting beta‐2 agonists for stable chronic obstructive pulmonary disease

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a condition associated with high morbidity, mortality and cost to the community. Patients often report symptomatic improvement with short‐acting beta‐2 agonists (SABA) and anticholinergic bronchodilator medications, and both are recommended...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cochrane Database Syst Rev
Egile Nagusiak: Appleton, Sarah, Jones, Terry, Poole, Phillippa, Pilotto, Louis, Adams, Robert, Lasserson, Toby J, Smith, Brian J, Muhammed, Julia
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons, Ltd 2006
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6513456/
https://ncbi.nlm.nih.gov/pubmed/16625543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001387.pub2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak